Diabatrol™ Performance

Nature’s Nutritional Supplement For Glucose Management

30 Day Results

30-Day Clinical Trial Results. Percent Change of Fasting Blood Glucose, Triglycerides, and HDL cholesterol (good cholesterol) after 30 days.

Randomized double-blind placebo controlled trial with 60 nonsmoking Type 2 diabetic men and women. Treatment group received the same dosage of active ingredient in Diabatrol twice daily for 30 days. All patients were taking prescription anti-diabetic drugs before and during the trial, so any blood sugar response during the trial can be attributed to the active ingredient in Diabatrol. No patient was taking a lipid lowering medication or had uncontrolled hypertension. Results are group averages comparing baseline with final results. Analysis of food records showed that dietary intake did not change over the study duration, the mean energy, fat, protein and carbohydrate intakes were not significantly different among groups. Results from the treatment group were statistically significant when compared to the placebo group. (P<0.001 to P<0.013)

60 Day Results

60 day Clinical Trial Results. Percent Change of Fasting serum Blood Glucose, A1c, and LDL cholesterol (bad cholesterol) after 60 days.

Randomized cross-over trial. 57 Type 2 diabetic men and women. Treatment group received the same dosage of active ingredient in Diabatrol twice daily for 60 days. All patients were taking prescription anti-diabetic drugs before and during the trial. The mean energy, fat, protein and carbohydrate intakes were not significantly different among groups.

Effects on Glucose Metabolism

Randomized, double blind controlled trials are the “gold standard” of the medical community. The 30-day clinical trial meets these criteria and documents the blood glucose lowering benefits derived from the natural active ingredients in Diabatrol. The 60-day clinical research illustrates the glucose metabolism benefits from the active ingredients in Diabatrol when taken for a 60-day period. Fasting glucose levels were reduced 33% (52 points) and A1c glycated hemoglobin test readings were reduced 15% (1.6 points). These performances demonstrate the value of a nutritional nutraceutical in complementing diabetic medications. These results were peer reviewed and published in the Journal of Nutritional Biochemistry.1 When consumed on a daily basis, clinical studies and follow-up consumer observations show that benefits derived from the active ingredients in Diabatrol are maximized over a 60 to 90 day period. Results vary depending upon duration and severity of elevated blood sugar levels and your overall health conditions.

Effects on Fatty acids and Cholesterol

Insulin resistance in patients with Type 2 diabetes and pre-diabetes is frequently associated with high triglyceride and low HDL (good cholesterol) levels.2- 6 Heart disease is the most common complication for patients with diabetes and pre-diabetes. Unhealthy high levels of triglycerides and LDL cholesterol and low levels of HDL cholesterol are major factors in cardiovascular disease risk. Lowering unhealthy LDL cholesterol and triglyceride levels and improving HDL levels are important aspects of minimizing heart disease risks. The active ingredients in Diabatrol have been clinically documented to lower LDL cholesterol and triglycerides in humans and animals.1, 7, 8 Diabatrol contains high levels of unique antioxidants not found in other whole grain products. These unique tocotrienols appear to lower LDL cholesterol levels and improve HDL levels.1, 9

References:
1. Qureshi AA, et al. Effects of Stabilized Rice Bran, its Soluble and Fiber Fractions on Blood Glucose Levels and Serum Lipid Parameters in Humans with Diabetes Mellitus Types I and 2. Journal of Nutritional Biochemistry. 2002. 13:175-187.
2. Simonen PP, et al. Diabetes Contributes to Cholesterol Metabolism Regardless of Obesity. Diabetes Care. 2002. 1511-1515.
3. Bloomgarden ZT. American Association of Clinical Endocrinologists (AACE) Consensus Conference on the Insulin Resistance Syndrome. Diabetes Care. 2003. 26:1297-1303.
4. Reaven GM. Role of Insulin Resistance in Human Disease. Diabetes. 1988. 37:1595–607.
5. Saltiel AR. The Molecular and Physiological Basis of Insulin Resistance: Emerging Implications for Metabolic and Cardiovascular Diseases. Journal of Clinical Investigation. 2000. 106:163-164.
6. Pihlajamäki, J. et al. Insulin Resistance is Associated with Increased Cholesterol Synthesis and Decreased Cholesterol Absorption in Normoglycemic Men. Journal of Lipid Research. 2004. 45:507-512.
7. Ann L. Gerhardt, et al. Full-Fat Rice Bran and Oat Bran Similarly Reduce Hypercholesterolemia in Humans. The Journal of Nutrition. 1998. 128: 865-869.
8. Sanders T, et al. The Influence of Rice Bran on plasma lipids and lipoproteins in Human volunteers. European Journal of Clinical Nutrition. 1992; 46: 167-172
9. Qureshi A, et al. Novel Tocotrienols of Rice Bran Suppress Cholesterogensis in Heredierary Hyper cholestemy swine. Journal of Nutrition. 2001; 131(2): 223-30.